Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, BICO Group AB's Enterprise Value is kr963 Mil.
BICO Group AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was kr39 Mil. Therefore, BICO Group AB's EV-to-OCF for today is 24.62.
The historical rank and industry rank for BICO Group AB's EV-to-OCF or its related term are showing as below:
CHIX:BICOs'
s EV-to-OCF Range Over the Past 10 Years
Min: -7924.83 Med: -64.25 Max: 53.35
Current: 22.78
During the past 10 years, the highest EV-to-OCF of BICO Group AB was 53.35. The lowest was -7924.83. And the median was -64.25.
CHIX:BICOs's EV-to-OCF is ranked worse than 79.13% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 7.89
vs CHIX:BICOs: 22.78
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
BICO Group AB's PE Ratio (TTM) for today is calculated as:
BICO Group AB's share price for today is kr45.75.
BICO Group AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-13.980.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
BICO Group AB EV-to-OCF Related Terms
BICO Group AB EV-to-OCF Historical Data
* Premium members only.
The historical data trend for BICO Group AB's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, BICO Group AB's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BICO Group AB EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BICO Group AB's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where BICO Group AB's EV-to-OCF falls into.
BICO Group AB's current Enterprise Value is kr963 Mil.
BICO Group AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr39 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BICO Group AB (CHIX:BICOS) has a EV-to-OCF of 24.62 as of Aug. 03, 2026. According to the industry distribution chart, BICO Group AB ranks #675 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 79.1%.
Is BICO Group AB's EV-to-OCF too high?
BICO Group AB's current EV-to-OCF is 24.62. The Medical Devices & Instruments industry median EV-to-OCF is 7.89. BICO Group AB's value of 24.62 is 212% above this industry median. Based on the distribution chart, BICO Group AB ranks #675 out of 853 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, BICO Group AB has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does BICO Group AB's EV-to-OCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, BICO Group AB ranks #675 out of 853 companies for EV-to-OCF. This places BICO Group AB in the lower half of its industry. The industry median EV-to-OCF is 7.89. BICO Group AB's value of 24.62 is 212% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.89, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BICO Group AB's current EV-to-OCF of 24.62 is 212% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BICO Group AB's current EV-to-OCF is 24.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BICO Group AB stock overvalued right now?
BICO Group AB (CHIX:BICOS) has a current EV-to-OCF of 24.62. The stock's GF Value™ is kr104.25, compared to a current price of kr45.75 — trading 56.1% below its estimated fair value. The current EV-to-OCF is 24.62 and 212% above the Medical Devices & Instruments industry median of 7.89. BICO Group AB's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For BICO Group AB (CHIX:BICOS), the current EV-to-OCF is 24.62 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BICO Group AB (CHIX:BICOS) Overvalued in 2026?
Based on GuruFocus' analysis, BICO Group AB stock appears to be undervalued.
The current stock price of kr45.75 is trading 56.1% below its estimated GF Value™ of kr104.25.
Key valuation signals for CHIX:BICOS:
EV-to-OCF: 24.62
GF Value™: kr104.25 vs. price of kr45.75 (56.1% below fair value)
Industry Position: 212% above the Medical Devices & Instruments median (#675 of 853)
No single metric tells the full story. See the CHIX:BICOS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BICO Group AB provides hardware, laboratory automation software, and products to automate and increase efficiency in workflows for pharma and biotech companies. Its portfolio includes automated workstations, lab automation software, microscopes and live-cell imaging, 3D cell culture and bioprinting, single-cell dispensing, liquid handling, mixing technologies, and consumables. The Group operates through two segments: Life Science Solutions, the maximum revenue generator, including CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, Cellenion, CELLINK, and BioMatrix, and Lab Automation, consisting of Biosero, which provides the Green Button Go Suite software and automation integration services.
62GF Score
Get the complete analysis for CHIX:BICOS
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:BICOS has been successfully added to your 
